Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Andrea Haake, Kevin Nguyen, Lauren Friedman, Binu Chakkamparambil & George T Grossberg. (2020) An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer’s disease. Expert Opinion on Drug Safety 19:2, pages 147-157.
Read now
Read now
Ryoko Nakagawa, Takashi Ohnishi, Hisanori Kobayashi, Toshio Yamaoka, Tsutomu Yajima, Ai Tanimura, Toshiya Kato & Kazutake Yoshizawa. (2017) Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting. Neuropsychiatric Disease and Treatment 13, pages 1115-1124.
Read now
Read now
Amira S. Hanafy, Ragwa M. Farid, Maged W. Helmy & Safaa S. ElGamal. (2016) Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management. Drug Delivery 23:8, pages 3111-3122.
Read now
Read now
Articles from other publishers (11)
Qiang Zhang, Jingyue Liu, Li Chen & Ming Zhang. (2022) Promoting Endogenous Neurogenesis as a Treatment for Alzheimer’s Disease. Molecular Neurobiology 60:3, pages 1353-1368.
Crossref
Crossref
Mariola Herbet, Jarosław Widelski, Iwona Piątkowska-Chmiel, Kamil Pawłowski, Aleksandra Dymek & Tomasz Mroczek. (2022) Amaryllidaceae, Lycopodiaceae Alkaloids and Coumarins—A Comparative Assessment of Safety and Pharmacological Activity. Journal of Clinical Medicine 11:15, pages 4291.
Crossref
Crossref
Łucja Justyna Walczak-Nowicka & Mariola Herbet. (2021) Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis. International Journal of Molecular Sciences 22:17, pages 9290.
Crossref
Crossref
Gabriella Sousa Santos, Simone Batista Pires Sinoti, Fabrício Tavares Cunha de Almeida, Dâmaris Silveira, Luiz Alberto Simeoni & Kicia Karinne Pereira Gomes-Copeland. (2020) Use of galantamine in the treatment of Alzheimer's disease and strategies to optimize its biosynthesis using the in vitro culture technique. Plant Cell, Tissue and Organ Culture (PCTOC) 143:1, pages 13-29.
Crossref
Crossref
Tingting Zhang, Nanyang Liu, Hongfu Cao, Wei Wei, Lina Ma & Hao Li. (2020) Different Doses of Pharmacological Treatments for Mild to Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Crossref
Ruth Knight, Mizanur Khondoker, Nicholas Magill, Robert Stewart & Sabine Landau. (2018) A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia. Dementia and Geriatric Cognitive Disorders 45:3-4, pages 131-151.
Crossref
Crossref
William James Deardorff & George T. Grossberg. 2018. Clinical Psychopharmacology for Neurologists. Clinical Psychopharmacology for Neurologists
151
180
.
Maitane Ortiz-Virumbrales, Cesar L. Moreno, Ilya Kruglikov, Paula Marazuela, Andrew Sproul, Samson Jacob, Matthew Zimmer, Daniel Paull, Bin Zhang, Eric E. Schadt, Michelle E. Ehrlich, Rudolph E. Tanzi, Ottavio Arancio, Scott Noggle & Sam Gandy. (2017) CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2
N141I
neurons. Acta Neuropathologica Communications 5:1.
Crossref
Crossref
I. V. Kolykhalov. (2016) Current approaches to optimize treatment of dementia and Alzheimer's disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:6, pages 87.
Crossref
Crossref
Nuala Livingstone, Jennifer Hanratty, Rupert McShane & Geraldine Macdonald. (2015) Pharmacological interventions for cognitive decline in people with Down syndrome. Cochrane Database of Systematic Reviews 2015:10.
Crossref
Crossref
Carina Wattmo, Elisabet Londos & Lennart Minthon. (2015) Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services. Dementia and Geriatric Cognitive Disorders 40:5-6, pages 297-310.
Crossref
Crossref